Organization

UCLA Radiation Oncology

1 abstract

Abstract

Early findings from the GARUDA trial: The impact of a genetic signature of late radiation toxicity on prostate cancer treatment decision making.

Org: UCLA Radiation Oncology, University of California Irvine, UCLA Department of Radiation Oncology, Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China, University of California Los Angeles,